Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 1/20 | 0.39 |
| ▸ | SKP2 | Q13309 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.34 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | NQO1 | P15559 | 1/20 | 0.33 |
| ▸ | ESR1 | P03372 | 1/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.33 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.33 |
| ▸ | PRKACA | P17612 | 1/20 | 0.33 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8827605 | 0.85 | CDK1 (0.42) | CNR1SKP2 | |
| SCHEMBL6372615 | 0.82 | ALOX15 (0.41) | ADRB2ESR1ESR2ALDH1A1LMNA | |
| SCHEMBL585504 | 0.82 | DAO (0.49) | KMT2A | |
| SCHEMBL6904685 | 0.82 | SKP2 (0.37) | SKP2POLBALDH1A1MEN1GAA | |
| SCHEMBL1257233 | 0.82 | DAO (0.49) | — | |
| SCHEMBL6373228 | 0.82 | ESR1 (0.57) | CNR1ESR1ESR2ALDH1A1GAA | |
| SCHEMBL27464297 | 0.81 | SKP2 (0.37) | CNR1SKP2ESR1ESR2ALDH1A1 | |
| SCHEMBL15609627 | 0.80 | RAPGEF4 (0.33) | ALDH1A1LMNA | |
| SCHEMBL2560484 | 0.80 | ALDH1A1 (0.37) | CNR1POLBNQO1ESR1ESR2 | |
| SCHEMBL29597103 | 0.79 | PTGS1 (0.45) | CNR1SKP2POLBESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 141 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220002632-A1 | APPARATUS AND COMPOSITIONS FOR IMPROVING SCENT DELIVERY | THE PROCTER AND GAMBLE COMPANY | 2022-01-06 | — | — | US | claimed |
| US-20220002633-A1 | APPARATUS AND COMPOSITIONS FOR IMPROVING SCENT DELIVERY | THE PROCTER AND GAMBLE COMPANY | 2022-01-06 | — | — | US | claimed |
| CN-113412327-A | Consumer product compositions with perfume encapsulates | 宝洁公司 | 2021-09-17 | — | — | CN | claimed |
| US-12036341-B2 | Freshening compositions and methods of atomizing freshening compositions with a thermally-actuated microfluidic cartridge | THE PROCTER & GAMBLE COMPANY (US) | 2024-07-16 | — | — | US | disclosed |
| EP-3999344-B1 | METHOD OF ATOMIZING A FLUID COMPOSITION | PROCTER & GAMBLE (US) | 2024-06-05 | — | — | EP | disclosed |
| WO-2024108076-A1 | AEROSOL DISPENSER AND NOZZLE WITH REDUCED DRIP | THE PROCTER & GAMBLE COMPANY (US) | 2024-05-23 | — | — | WO | disclosed |
| US-20240166426-A1 | AEROSOL DISPENSER AND NOZZLE WITH REDUCED DRIP | THE PROCTER AND GAMBLE COMPANY | 2024-05-23 | — | — | US | disclosed |
| WO-2024108077-A1 | AEROSOL DISPENSER AND NOZZLE | THE PROCTER & GAMBLE COMPANY (US) | 2024-05-23 | — | — | WO | disclosed |
| US-20240166427-A1 | AEROSOL DISPENSER AND NOZZLE | THE PROCTER AND GAMBLE COMPANY | 2024-05-23 | — | — | US | disclosed |
| EP-3431143-B1 | GELS COMPRISING A HYDROPHOBIC MATERIAL | PROCTER & GAMBLE INT OPERATIONS SA (CH) | 2024-02-28 | — | — | EP | disclosed |
| EP-3431144-B1 | GELS COMPRISING A HYDROPHOBIC MATERIAL | PROCTER & GAMBLE INT OPERATIONS SA (CH) | 2023-06-14 | — | — | EP | disclosed |
| US-20100111889-A1 | Malodor Control System | PROCTER & GAMBLE COMPANY, THE | 2010-05-06 | — | — | US | disclosed |
| US-20100093740-A1 | 5,6,7,8-TETRAHYDRO-IMIDAZO[1,5-A]PYRAZINE DERIVATIVES | ACTELION PHARMACEUTICALS LTD. (CH) | 2010-04-15 | — | — | US | disclosed |
| EP-2125823-A1 | 5,6,7,8-TETRAHYDRO-IMIDAZO[1,5-A]PYRAZINE DERIVATIVES | Actelion Pharmaceuticals Ltd. (CH) | 2009-12-02 | — | — | EP | disclosed |
| CN-101568542-A | 5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine derivatives | ACTELION PHARMACEUTICALS LTD (CH) | 2009-10-28 | — | — | CN | disclosed |
| US-20090099228-A1 | PYRAZOLO-TETRAHYDRO PYRIDINE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS | ACTELION PHARMACEUTICALS LTD. (CH) | 2009-04-16 | — | — | US | disclosed |
| US-20090099228-A1 | PYRAZOLO-TETRAHYDRO PYRIDINE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS | ACTELION PHARMACEUTICALS LTD. (CH) | 2009-04-16 | — | — | US | disclosed |
| WO-2008078291-A1 | 5,6,7,8-TETRAHYDRO-IMIDAZO[1,5-A]PYRAZINE DERIVATIVES | ACTELION PHARMACEUTICALS LTD (CH) | 2008-07-03 | — | — | WO | disclosed |
| WO-2007122591-A2 | PYRAZOLO-TETRAHYDRO PYRIDINE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS | ACTELION PHARMACEUTICALS LTD (CH) | 2007-11-01 | — | — | WO | disclosed |
| EP-0949238-A1 | SUBSTITUTED PROPIONYL DERIVATIVES | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 1999-10-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100093740-A1 | 5,6,7,8-TETRAHYDRO-IMIDAZO[1,5-A]PYRAZINE DERIVATIVES | HCRTR1, HCRTR2, NPY5R | CNR1 6/4885SKP2 3200/4885KCNH2 646/4885 |
| US-20090099228-A1 | PYRAZOLO-TETRAHYDRO PYRIDINE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS | HCRTR2, HCRTR1, OXTR | CNR1 31/4885SKP2 963/4885KCNH2 1263/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.